The BCBA project team will conduct a survey to evaluate and prioritize cardiovascular, metabolic, and neuro indications for an early stage company’s target discovery platform that leverages the power of comparative biology to develop therapeutics. The team will utilize primary and secondary research to evaluate the landscape for different disease indications based on i) current unmet needs, ii) therapeutic modes of action, iii) market opportunity, iv) clinical considerations, and v) competitive landscape. The BCBA team will construct a slide deck summarizing their findings and provide recommendations to guide the client’s business strategy. Throughout the project, team members will interact directly with the company’s CEO and co-founders, an industry mentor, and Biotech Connection – Bay Area leadership.